225 related articles for article (PubMed ID: 33597638)
21. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.
Gong H; Liu L; Cui L; Ma H; Shen L
Mol Carcinog; 2021 Sep; 60(9):644-657. PubMed ID: 34169564
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J
PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-1246 by Targeting AXIN2 and GSK-3β Overcomes Drug Resistance and Induces Apoptosis in Chemo-resistant Leukemia Cells.
Xie B; Li L; Zhang Z; Zhao L; Cheng J; Zhou C; Cheng J; Yan J; Chen J; Yi J; Wang B; Jin S; Wei H
J Cancer; 2021; 12(14):4196-4208. PubMed ID: 34093820
[No Abstract] [Full Text] [Related]
24. Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia.
Harr MW; Caimi PF; McColl KS; Zhong F; Patel SN; Barr PM; Distelhorst CW
Cell Death Differ; 2010 Sep; 17(9):1381-91. PubMed ID: 20300113
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Aurora kinase A activity enhances the antitumor response of beta-catenin blockade in human adrenocortical cancer cells.
Maria AG; Silva Borges K; Lira RCP; Hassib Thomé C; Berthon A; Drougat L; Kiseljak-Vassiliades K; Wierman ME; Faucz FR; Faça VM; Tone LG; Stratakis CA
Mol Cell Endocrinol; 2021 May; 528():111243. PubMed ID: 33716050
[TBL] [Abstract][Full Text] [Related]
26. Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.
Hall CP; Reynolds CP; Kang MH
Clin Cancer Res; 2016 Feb; 22(3):621-32. PubMed ID: 26080839
[TBL] [Abstract][Full Text] [Related]
27. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
[TBL] [Abstract][Full Text] [Related]
28. Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression.
Shah K; Moharram SA; Kazi JU
Clin Epigenetics; 2018; 10():83. PubMed ID: 29951132
[TBL] [Abstract][Full Text] [Related]
29. Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands.
Rider CF; Shah S; Miller-Larsson A; Giembycz MA; Newton R
PLoS One; 2015; 10(1):e0116773. PubMed ID: 25625944
[TBL] [Abstract][Full Text] [Related]
30. Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways.
Kitase Y; Barragan L; Qing H; Kondoh S; Jiang JX; Johnson ML; Bonewald LF
J Bone Miner Res; 2010 Dec; 25(12):2657-68. PubMed ID: 20578217
[TBL] [Abstract][Full Text] [Related]
31. Daphnetin ameliorates glucocorticoid-induced osteoporosis via activation of Wnt/GSK-3β/β-catenin signaling.
Wang Y; Chen J; Chen J; Dong C; Yan X; Zhu Z; Lu P; Song Z; Liu H; Chen S
Toxicol Appl Pharmacol; 2020 Dec; 409():115333. PubMed ID: 33171191
[TBL] [Abstract][Full Text] [Related]
32. Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by β-catenin stabilization.
Mrak E; Guidobono F; Moro G; Fraschini G; Rubinacci A; Villa I
J Cell Physiol; 2010 Nov; 225(3):701-8. PubMed ID: 20533307
[TBL] [Abstract][Full Text] [Related]
33. TAS-119, a novel selective Aurora A and TRK inhibitor, exhibits antitumor efficacy in preclinical models with deregulated activation of the Myc, β-Catenin, and TRK pathways.
Miura A; Sootome H; Fujita N; Suzuki T; Fukushima H; Mizuarai S; Masuko N; Ito K; Hashimoto A; Uto Y; Sugimoto T; Takahashi H; Mitsuya M; Hirai H
Invest New Drugs; 2021 Jun; 39(3):724-735. PubMed ID: 33409897
[TBL] [Abstract][Full Text] [Related]
34. Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia.
Spenerova M; Dzubak P; Srovnal J; Radova L; Burianova R; Konecny P; Salkova S; Novak Z; Pospisilova D; Stary J; Blazek B; Hak J; Votava T; Timr P; Kaiserova E; Bubanska E; Mihal V; Hajduch M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):422-7. PubMed ID: 23128824
[TBL] [Abstract][Full Text] [Related]
35. Dexamethasone inhibits BMP7-induced osteogenic differentiation in rat dental follicle cells via the PI3K/AKT/GSK-3β/β-catenin pathway.
Tang J; Qing MF; Li M; Gao Z
Int J Med Sci; 2020; 17(17):2663-2672. PubMed ID: 33162794
[TBL] [Abstract][Full Text] [Related]
36. Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Spijkers-Hagelstein JA; Mimoso Pinhanços S; Schneider P; Pieters R; Stam RW
Leukemia; 2013 Apr; 27(5):1063-71. PubMed ID: 23334362
[TBL] [Abstract][Full Text] [Related]
37. Wnt/β-catenin Pathway Modulates the Sensitivity of the Mutant FLT3 Receptor Kinase Inhibitors in a GSK-3β Dependent Manner.
Jiang J; Griffin JD
Genes Cancer; 2010 Feb; 1(2):164-76. PubMed ID: 21779446
[TBL] [Abstract][Full Text] [Related]
38. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
Han SS; Han S; Kamberos NL
Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
[TBL] [Abstract][Full Text] [Related]
39. GSK-3β mediates dexamethasone-induced pancreatic β cell apoptosis.
Guo B; Zhang W; Xu S; Lou J; Wang S; Men X
Life Sci; 2016 Jan; 144():1-7. PubMed ID: 26606859
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
